To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


View sample alert

Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Deposited Papers

Jan. 15 2008

Source Page: Table showing count of finished admission episodes where there was a primary or secondary diagnosis of alcoholic liver disease and alcoholic cirrhosis of the liver by gender and age for a) the East of England Strategic Health Authority in 2006/07 b) Southend on Sea Primary Care Trust 1997/98 - 2005/06 and c) South East Essex Primary Care Trust in 2006/07. 6 p.
Document: DEP2008-0112.xls (Excel)

Found: count of finished admission episodes where there was a primary or secondary diagnosis of alcoholic liver


Westminster Hall
Liver Disease and Liver Cancer - Thu 25 Apr 2024
Department of Health and Social Care

Mentions:
1: Navendu Mishra (Lab - Stockport) I beg to move,That this House has considered health inequalities in liver disease and liver cancer.It - Speech Link
2: Alison Thewliss (SNP - Glasgow Central) There is a real stigma around liver issues, which we must do our best to bust.We have a public health - Speech Link
3: Alison Thewliss (SNP - Glasgow Central) disease and liver cancer; we can prevent that progression if the public health imperative is there. - Speech Link


Written Question
Liver Cancer: Health Services
Tuesday 27th February 2024

Asked by: Rachael Maskell (Labour (Co-op) - York Central)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what recent assessment she has made of the effectiveness of (a) community liver health checks, (b) primary care pilots and (c) surveillance for hepatocellular carcinoma as part of NHS England's early detection of liver cancer programme.

Answered by Andrew Stephenson

The care of and treatment for patients with cancers, including liver cancer, is a priority for the Government. National Health Service cancer standards have been reformed with the support of clinicians to speed up diagnosis for patients, which means people will receive a diagnosis or have cancer ruled out within 28 days from urgent cancer referral from their general practice. NHS England’s Early diagnosis of Liver Cancer Programme is contributing to deliver the NHS Long Term Plan’s commitment to diagnose 75% of all cancers at stage one or two by 2028.  Identifying those at risk and ensuring patients are tested and referred to a surveillance programme, where necessary, will lead to improved patient outcomes.


Written Question
Liver Diseases
Tuesday 23rd July 2024

Asked by: John Hayes (Conservative - South Holland and The Deepings)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to help raise awareness of liver disease.

Answered by Andrew Gwynne - Parliamentary Under-Secretary (Department of Health and Social Care)

Awareness of liver disease can be raised by providing information to the public and by supporting health and care professionals to discuss liver disease with their patients. The NHS.UK website provides the public with essential information on types of liver disease, their possible causes, symptoms, treatment, and prevention. Further information is available at the following link:

https://www.nhs.uk/conditions/liver-disease/

In May 2022, the Department published guidance for health and care professionals on promoting awareness of liver disease in professional practice. Further information on this guidance is available at the following link:

https://www.gov.uk/government/publications/liver-disease-applying-all-our-health/liver-disease-applying-all-our-health#promoting-awareness-of-liver-disease-in-your-professional-practice

Furthermore, the United Kingdom’s clinical guidelines for alcohol treatment, published by the Office for Health Improvement and Disparities for consultation in October 2023, contain clinical guidance and advice for professionals on the early identification of liver disease among people with alcohol use disorders, and on the treatment of alcohol use disorders in people diagnosed with liver disease. Further information on the guidance is available at the following link:

https://www.gov.uk/government/publications/liver-disease-applying-all-our-health/liver-disease-applying-all-our-health

The Department is currently reviewing these guidelines following a consultation.


Deposited Papers

Oct. 12 2009

Source Page: Table showing the number of finished hospital admission episodes for the East of England with a primary diagnosis of (a) alcoholic liver disease and (b) cirrhosis of the liver from 1999/00 to 2007/08. 11 p.
Document: DEP2009-2489.xls (Excel)

Found: finished hospital admission episodes for the East of England with a primary diagnosis of (a) alcoholic liver


Written Question
Liver Diseases: Screening
Monday 9th September 2024

Asked by: Layla Moran (Liberal Democrat - Oxford West and Abingdon)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the adequacy of the pilot scheme for the Community Liver Health Check Programme.

Answered by Andrew Gwynne - Parliamentary Under-Secretary (Department of Health and Social Care)

Early detection of liver disease is vital to enable interventions and encourage behavioural change that can potentially lead to recovery. The Community Liver Health Check programme was established in June 2022 and aims to support the early detection and diagnosis of liver cancer, including hepatocellular carcinomas (HCC), the most common liver cancer. As of the end of July 2024, the programme has delivered over 66,000 FibroScans and referred over 4,700 people into six-monthly liver ultrasound surveillance. Across Thames Valley, which includes Oxfordshire, 1,430 FibroScans have been delivered, with 5% of people identified to be at risk of HCC.

The Community Liver Health Check programme has an evaluation underway, with the final report due in Spring 2025. The results of the evaluation will be considered by NHS England when deciding on next steps.

The Government has not made an assessment of the potential merits of establishing diagnostic centres specifically for the early diagnosis of liver disease, for either Oxfordshire or nationally. However, the National Health Service is continuing to roll out Community Diagnostic Centres (CDCs), many of which will have testing capability to support the early diagnosis of liver disease, including some CDCs that offer FibroScans. There are currently plans for 14 CDCs to offer FibroScans by the end of this financial year, 10 of which are currently providing the test, and have delivered 2,144 tests in 2024/25.


Written Question
Liver Diseases: Screening
Monday 9th September 2024

Asked by: Layla Moran (Liberal Democrat - Oxford West and Abingdon)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether he has made a recent assessment of the potential merits of establishing permanent Early Liver Disease Diagnostics centres to deliver non-invasive diagnoses (a) in Oxfordshire and (b) nationally.

Answered by Andrew Gwynne - Parliamentary Under-Secretary (Department of Health and Social Care)

Early detection of liver disease is vital to enable interventions and encourage behavioural change that can potentially lead to recovery. The Community Liver Health Check programme was established in June 2022 and aims to support the early detection and diagnosis of liver cancer, including hepatocellular carcinomas (HCC), the most common liver cancer. As of the end of July 2024, the programme has delivered over 66,000 FibroScans and referred over 4,700 people into six-monthly liver ultrasound surveillance. Across Thames Valley, which includes Oxfordshire, 1,430 FibroScans have been delivered, with 5% of people identified to be at risk of HCC.

The Community Liver Health Check programme has an evaluation underway, with the final report due in Spring 2025. The results of the evaluation will be considered by NHS England when deciding on next steps.

The Government has not made an assessment of the potential merits of establishing diagnostic centres specifically for the early diagnosis of liver disease, for either Oxfordshire or nationally. However, the National Health Service is continuing to roll out Community Diagnostic Centres (CDCs), many of which will have testing capability to support the early diagnosis of liver disease, including some CDCs that offer FibroScans. There are currently plans for 14 CDCs to offer FibroScans by the end of this financial year, 10 of which are currently providing the test, and have delivered 2,144 tests in 2024/25.


Arms Length Body Publication (Awaiting development)
NICE

Source Page: Semaglutide for treating non-alcoholic steatohepatitis with significant liver fibrosis ID 6458
Document: 13408-Semaglutide-for-Non-Alcoholic-Steatohepatitis-V1.0-OCT2023-NON-CONF.pdf (nihr.ac.uk) (PDF)

Found: Semaglutide for treating non-alcoholic steatohepatitis with significant liver fibrosis ID 6458


Written Question
Liver Diseases: Screening
Thursday 8th August 2024

Asked by: John Hayes (Conservative - South Holland and The Deepings)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what steps he is taking to help support early diagnosis of liver disease.

Answered by Andrew Gwynne - Parliamentary Under-Secretary (Department of Health and Social Care)

Early detection of liver disease, including in rural and deprived areas, is vital to enable interventions and encourage behavioural change that can potentially lead to recovery. Liver disease is also one of the primary risk factors for liver cancer.

NHS England is ensuring that National Health Service laboratories across the country receive the upgrades to laboratory digital capabilities required to offer Intelligent Liver Function Tests, which are effective at quickly identifying patients at high risk of liver disease and cirrhosis. We will work with the NHS to further support investment into pathology laboratories and the development of national early diagnosis pathways.

The Community Liver Health Check programme is delivering Fibroscans and lifestyle advice in the community, from mobile units across many local areas, to identify people at high risk of liver cancer, targeting drug and alcohol service users, homeless people, and people with type 2 diabetes, among others. As of the end of June 2024, the programme has delivered over 61,000 Fibroscans and referred over 4,500 people into liver ultrasound surveillance every six months.

The primary care case finding programme, which uses primary care records to identify patients at high risk of cirrhosis and offer them blood tests and Fibroscans, began in 12 primary care networks in January 2024. As of the end of June 2024, the pilot had tested over 8,900 patients, and referred 142 into liver ultrasound surveillance every six months.

People from deprived backgrounds are more at risk of liver disease and liver cancer, and these programmes specifically target those with the highest risk, to identify the most in need patients first.


Written Question
Liver Diseases: Screening
Thursday 8th August 2024

Asked by: John Hayes (Conservative - South Holland and The Deepings)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, if he will take steps with NHS England to help improve testing facilities for suspected liver disease in (a) rural and (b) deprived areas.

Answered by Andrew Gwynne - Parliamentary Under-Secretary (Department of Health and Social Care)

Early detection of liver disease, including in rural and deprived areas, is vital to enable interventions and encourage behavioural change that can potentially lead to recovery. Liver disease is also one of the primary risk factors for liver cancer.

NHS England is ensuring that National Health Service laboratories across the country receive the upgrades to laboratory digital capabilities required to offer Intelligent Liver Function Tests, which are effective at quickly identifying patients at high risk of liver disease and cirrhosis. We will work with the NHS to further support investment into pathology laboratories and the development of national early diagnosis pathways.

The Community Liver Health Check programme is delivering Fibroscans and lifestyle advice in the community, from mobile units across many local areas, to identify people at high risk of liver cancer, targeting drug and alcohol service users, homeless people, and people with type 2 diabetes, among others. As of the end of June 2024, the programme has delivered over 61,000 Fibroscans and referred over 4,500 people into liver ultrasound surveillance every six months.

The primary care case finding programme, which uses primary care records to identify patients at high risk of cirrhosis and offer them blood tests and Fibroscans, began in 12 primary care networks in January 2024. As of the end of June 2024, the pilot had tested over 8,900 patients, and referred 142 into liver ultrasound surveillance every six months.

People from deprived backgrounds are more at risk of liver disease and liver cancer, and these programmes specifically target those with the highest risk, to identify the most in need patients first.